A Study Using Contrast Enhanced Digital Mammography in Addition to Diagnostic Mammography and Ultrasound for Suspicious Breast Lesions to Decrease Biopsy Rates

Overview

About this study

The purpose of this study is to evaluate the accuracy of diagnosis with contrast enhanced digital mammography when used in addition to standard mammography or ultrasound in patients with suspicious findings.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria

Women aged 30 or older
With BI-RADS 4 lesions as determined on mammography or ultrasound

Exclusion Criteria

Pregnant
History of allergic reaction to an iodinated contrast agent

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location	Status	Contact
Scottsdale/Phoenix, Ariz. Mayo Clinic principal investigator Bhavika Patel, M.D.	Closed for enrollment	Contact information: Marilyn Wood CCRP (480)342-3484 Wood.Becky@mayo.edu

Mayo Clinic Location

Status

Contact

Scottsdale/Phoenix, Ariz.

Mayo Clinic principal investigator

Bhavika Patel, M.D.

Closed for enrollment

Contact information:

Marilyn Wood CCRP

(480)342-3484

Wood.Becky@mayo.edu

More information

Publications

Publications are currently not available

Clinical Trials